Mode
Text Size
Log in / Sign up

Extrusion-based printing dominates biofabrication for craniomaxillofacial reconstruction in scoping reviewBiofabrication strategies for face reconstruction show mixed progress in recent research

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that most craniomaxillofacial biofabrication research remains preclinical, with extrusion-based printing and composite materials dominating the literature.

This is a scoping review that mapped the landscape of biofabrication strategies for craniomaxillofacial reconstruction, analyzing 107 studies published between 2010 and 2025. The authors synthesized findings on fabrication strategy distribution, material systems, and construct complexity. Extrusion-based printing was the most frequent approach, reported in 70.1% of studies, and composite material systems were used in 59.8% of studies. Complex multi-tissue constructs were investigated in 21.5% of studies but evaluated exclusively in vitro or in small animal models. Bio-additive incorporation predominantly focused on osteogenic enhancement, and outcome reporting favored structural characteristics over assessments of functional recovery.

The review identified key gaps and limitations. Research activity is clustered around a limited set of approaches, and relatively limited attention is paid to angiogenic support. Most complex multi-tissue constructs were evaluated only in vitro or in small animal models, and outcome reporting favored structural characteristics over functional recovery. The authors conclude that progress toward translation is likely to depend on closer integration of fabrication strategies, biological design considerations, and function-oriented evaluation frameworks. Practice relevance is restrained given the early stage of evidence and limited translational maturity.

Scientists looked at how we build new tissue for the face and jaw. They found that most research uses a specific printing method called extrusion-based printing. This approach was the most common choice among the studies reviewed. Many of these projects also mix different materials to create stronger structures. About sixty percent of the work used these composite systems. However, the research has a clear gap. Most complex projects were tested only in a lab dish or on small animals. Very few studies looked at how these structures work in living humans. The focus was heavily on making the tissue look right or hold its shape. Researchers rarely checked if the new tissue actually helped patients recover their function. There was also very little attention given to helping new blood vessels grow into the new tissue. This is a critical need for any successful repair. The studies did not report safety issues or side effects because they were mostly lab work. The path to using these new techniques in hospitals depends on changing how we test them. We must move beyond just building strong structures. We need to prove these methods help people heal and function better in real life.

What this means for you:
Current biofabrication research focuses on structure, not yet on real-world function or safety.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Reconstruction of the craniomaxillofacial (CMF) region poses combined structural and biological challenges that are difficult to address using conventional approaches. Although biofabrication has gained attention in this context, its progression across fabrication strategies and stages of translational validation has not been examined in a consolidated manner. A scoping review was conducted in accordance with PRISMA-ScR recommendations. Relevant studies published between 2010 and 2025 were identified and examined using a four-dimensional analytical framework (spatial, biological, temporal, and biomechanical complexity) to evaluate fabrication strategy, construct complexity, bio-additive integration, and translational maturity. Analysis of 107 studies indicated that research activity clustered around a limited set of approaches, most frequently extrusion-based printing (70.1%) in combination with composite material systems (59.8%). Although 21.5% of studies investigated complex multi-tissue constructs, most of these were evaluated exclusively in vitro or in small animal models. Bio-additive incorporation predominantly focused on osteogenic enhancement, with relatively limited attention to angiogenic support. Across studies, outcome reporting favored structural characteristics over assessments of functional recovery. These findings highlight a gap between increasing construct complexity in CMF biofabrication and validation in functionally and clinically relevant models. Progress toward translation is likely to depend on closer integration of fabrication strategies, biological design considerations, and function-oriented evaluation frameworks.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.